Pure Bioscience Inc (PURE) - Financial and Strategic SWOT Analysis Review

Pure Bioscience Inc (PURE) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pure Bioscience Inc (Pure Bioscience) develops and commercializes proprietary antimicrobial products. The company’s products find application in the areas of food processing, food service, , healthcare, and personal care, and food safety. Its initial products contain a non-toxic antimicrobial agent, broad-spectrum, , silver dihydrogen citrate (SDC). The company markets products under Axenohl, Axen, Silverion, and PURE brand names. It also manufactures and sells dispensing equipment and SDC-based formulations to manufacturers for use as a raw material ingredient. Pure Bioscience is headquartered in Rancho Cucamonga, California, the US.

Pure Bioscience Inc Key Recent Developments

Dec 13,2019: PURE Bioscience reports fiscal 2020 Q1 financial results
Oct 29,2019: PURE Bioscience reports fiscal 2019 year-end financial results
Jul 09,2019: PURE Bioscience announces initiatives to accelerate drive toward profitability and reduce overhead
Jun 13,2019: PURE Bioscience reports fiscal 2019 third quarter and nine-month financial results
Dec 13,2018: PURE Bioscience Reports Fiscal 2019 Q1 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Pure Bioscience Inc - Key Facts
Pure Bioscience Inc - Key Employees
Pure Bioscience Inc - Key Employee Biographies
Pure Bioscience Inc - Major Products and Services
Pure Bioscience Inc - History
Pure Bioscience Inc - Company Statement
Pure Bioscience Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Pure Bioscience Inc - Business Description
R&D Overview
Pure Bioscience Inc - SWOT Analysis
SWOT Analysis - Overview
Pure Bioscience Inc - Strengths
Pure Bioscience Inc - Weaknesses
Pure Bioscience Inc - Opportunities
Pure Bioscience Inc - Threats
Pure Bioscience Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Pure Bioscience Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 13, 2019: PURE Bioscience reports fiscal 2020 Q1 financial results
Oct 29, 2019: PURE Bioscience reports fiscal 2019 year-end financial results
Jul 09, 2019: PURE Bioscience announces initiatives to accelerate drive toward profitability and reduce overhead
Jun 13, 2019: PURE Bioscience reports fiscal 2019 third quarter and nine-month financial results
Dec 13, 2018: PURE Bioscience Reports Fiscal 2019 Q1 Financial Results
Oct 25, 2018: PURE Bioscience reports fiscal 2018 year-end financial results
Jul 02, 2018: PURE Bioscience Raises $500,000 in Unsecured Promissory Note - Appoints Ivan Chen to Board of Directors
Jun 13, 2018: PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Pure Bioscience Inc, Key Facts
Pure Bioscience Inc, Key Employees
Pure Bioscience Inc, Key Employee Biographies
Pure Bioscience Inc, Major Products and Services
Pure Bioscience Inc, History
Pure Bioscience Inc, Other Locations
Pure Bioscience Inc, Key Competitors
Pure Bioscience Inc, Ratios based on current share price
Pure Bioscience Inc, Annual Ratios
Pure Bioscience Inc, Annual Ratios (Cont...1)
Pure Bioscience Inc, Interim Ratios
Pure Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Pure Bioscience Inc, Performance Chart (2015 - 2019)
Pure Bioscience Inc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook